logo
  • Home
  • News
Menu

Children’s medicines ‘quite challenging’ to develop: AFT Pharmaceutical CEO

Home / Stock Analysis / Children’s medicines ‘quite challenging’ to develop: AFT Pharmaceutical CEO
Article feature image

Children’s medicines ‘quite challenging’ to develop: AFT Pharmaceutical CEO

14 Jul Stock Analysis

New Zealand drug company AFT Pharmaceuticals has gained regulatory approval for its liquid pain relief developed for children, in Europe, and hopes to eventually get United States approval.
Italy and Malta have approved the use of Maxigesic Oral Liquid,…

Click here to view the original article.

Tags:
featured, Global, Stuff.co.nz
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1768132122_premium-articleshow.jpg
+

Technical analysis: Two Trades for Today: A quick commerce major for a 5.6% upmove, a large-cap oil exploration stock for an almost 6% rise

11 Jan Stock Analysis
lseg-share-price-ends-higher-as-ftse-hits-record-what-to-watch-before-london-trade-resumes-featured.jpeg
+

LSEG share price ends higher as FTSE hits record — what to watch before London trade resumes

11 Jan Stock Analysis

recent post

  • 108240821-1765480720880-gettyimages-2250661564-US_CAPITOL.jpeg

    Lawmakers are preparing to try again

    Jan 11 2026
  • 6b5707c73689e80f64b4f09d699b1641.jpeg

    Warren Buffett once explained how to

    Jan 11 2026
  • 1760614863_news-story.jpg

    Russians ask government hotlines whether pensions

    Jan 11 2026
  • a0c8fa2e-dfbe-42dd-8b0e-eb6099af7a98-960x640.jpg

    ChatGPT’s Stunning Crypto Prediction: This Hidden

    Jan 11 2026
  • 1760614863_news-story.jpg

    CryptoQuant founder slams X for penalizing

    Jan 11 2026

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.